BlackRock Institutional Trust’s iRadimed IRMD Stock Holding History

BlackRock Institutional Trust’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$714K	Buy	64,334 +11,687	+22%	+$126K	﹤0.01%	3378
2016 Q3	$894K	Sell	52,647 -8,252	-14%	-$153K	﹤0.01%	3334
2016 Q2	$1.32M	Sell	60,899 -13,565	-18%	-$244K	﹤0.01%	3207
2016 Q1	$1.43M	Buy	74,464 +22,202	+42%	+$425K	﹤0.01%	3176
2015 Q4	$1.47M	Sell	52,262 -2,405	-4%	-$68K	﹤0.01%	3223
2015 Q3	$1.33M	Sell	54,667 -3,610	-6%	-$86.4K	﹤0.01%	3244
2015 Q2	$1.36M	Buy	58,277 +58,177	+58,177%	+$1.06M	﹤0.01%	3255
2015 Q1	$2K	Buy	+100	New	+$1.48K	﹤0.01%	3839

Other funds holding IRMD

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $9.05B AUM 13.04% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Institutional Trust's IRMD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its iRadimed (IRMD) stake by 22% in Q4 2016, buying an estimated $126K and bringing the position to 64,334 shares worth $714K. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

BlackRock Institutional Trust first reported a position in IRMD in Q1 2015 and has held it in 8 quarters since. The position peaked at $1.47M in Q4 2015. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

BlackRock Institutional Trust held 64,334 shares of iRadimed worth $714K as of Q4 2016.
BlackRock Institutional Trust bought 11,687 iRadimed shares in Q4 2016, an estimated $126K.
iRadimed made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3378 holding.
BlackRock Institutional Trust first reported a position in iRadimed in Q1 2015 and has held it in 8 quarters since.
BlackRock Institutional Trust's iRadimed position peaked at $1.47M in Q4 2015.
58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.